• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us
Sleep Diagnosis and Therapy

Sleep Diagnosis and Therapy

Official Publication of the American Sleep and Breathing Academy

Study Deems CPAP “Cost Effective”

May 2, 2014 by admin

 

With proper compliance, CPAP is clinically effective, but is it cost effective? Researchers at the INOVA Fairfax Hospital, Fairfax, Va, believe the answer is yes.

 

In the study which will appears in the May edition of Sleep Diagnosis and Therapy, lead researcher Mahadevappa Hunasikatti, MD, DPM, FCCP, factored in direct and indirect (work-related injuries, lost work productivity) costs to determine that CPAP compared favorably with many medical treatments, such as cholesterol lowering medications and biologic agents in the treatment of rheumatoid arthritis.

 

“Untreated OSA leads to multiple medical problems such as hypertension, cardiovascular disease, injuries, and mood disorders that potentially increase medical care utilization,” concludes Hunasikatti. “Mean medical costs of patients with OSA were significantly   greater ($ 2720) than those of matched controls ($1384).”

 

In addition, cost effectiveness of CPAP was compared to dental devices and life style advice for adults. “On average, CPAP was associated with higher cost and Quality –adjusted life-year (QALY) compared to dental devices or life style,” wrote researchers. “In the case base case analysis the incremental cost effectiveness of ratio (ICER) for CPAP compared to dental devices was around 4,000 pounds per QALY (2005-06 prices). The probability that CPAP is more cost effective than dental devices or life style advice at a threshold value of 20,000 pounds per QALY was 0.78 for men and 0.80 for women.”

 

As for CPAP’s effect on the financial health of the nation, CPAP results in long-term health benefit, as measured by the use of health care services. “The CPAP is also cost effective in American context where they used Markov model and found that ICER of CPAP was found to be $3,354 dollars per QALY,” wrote researchers.

Filed Under: Blog

Primary Sidebar

More to See

Snoring, American Sleep and Breathing Academy and the NY Times

August 23, 2022 By admin

Jazz Pharma Presents 17 New Posters for SLEEP 2022

June 6, 2022 By admin

Tags

apnea CPAP Health Home Sleep Home Sleep Testing insomnia narcolepsy obstructive sleep apnea Sleep sleep apnea sleep apnea symptoms sleep apnea syndrome sleep apnea treatment sleep appliances sleep buisness Sleep Business sleep center Sleep Centers sleep community sleep diagnosis sleep diagnostic sleep diagnostics sleep disease sleep disorder sleep disorder center sleep disordered breathing sleep disorders sleep heart health sleep industry sleeping Sleep Lab sleep labs sleep management sleep medicine sleep monitor sleep physicians sleep problems sleep studies sleep study sleep technologist sleep test sleep testing Technology therapy Treatment

Footer

About SleepDT

SleepDT Sleep Diagnosis and Therapy is a clinical Journal for allied Sleep Professionals, Neurologists, Psychiatrists, Pulmonologists, Primary Care Physicians, and other medical specialists. We also advocate on behalf of patient care in the field of Sleep Medicine

Recent

  • SUPPORT AND PROMOTE DENTAL SLEEP MEDICINE IN 2023!
  • Snoring, American Sleep and Breathing Academy and the NY Times
  • Jazz Pharma Presents 17 New Posters for SLEEP 2022
  • AJMC Hypes SLEEP 2022
  • Avadel Pharmaceuticals’ Stock Falls

NAVIGATION

  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us

Copyright © 2023 · Sleep Diagnosis and Therapy